Article ID Journal Published Year Pages File Type
5699875 Clinical Oncology 2006 5 Pages PDF
Abstract
We found that the ICTP is not a superior serum marker for bone metastases compared with ALP or PSA. Our study suggests, however, that the ICTP measurement is useful in a certain subset of men with the combination of PSA and ALP in distinguishing men with bone metastasis from those without.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , , , , , , ,